Sign Up to like & get
recommendations!
0
Published in 2020 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13349
Abstract: cebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials. Lancet 2017; 390: 276–8. 3. Vaccaro M, Cannav o SP, Imbesi S et al. Increased…
read more here.
Keywords:
sweet syndrome;
like sweet;
syndrome caused;
caused adalimumab ... See more keywords